Fei He

1.5k total citations
67 papers, 1.1k citations indexed

About

Fei He is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Fei He has authored 67 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 24 papers in Cancer Research and 14 papers in Oncology. Recurrent topics in Fei He's work include Cancer-related molecular mechanisms research (19 papers), RNA modifications and cancer (11 papers) and MicroRNA in disease regulation (8 papers). Fei He is often cited by papers focused on Cancer-related molecular mechanisms research (19 papers), RNA modifications and cancer (11 papers) and MicroRNA in disease regulation (8 papers). Fei He collaborates with scholars based in China, United States and Japan. Fei He's co-authors include Zhijian Hu, Lin Cai, Zheng Lin, Qiuping Xu, Shuang Liu, Sheng Zhang, Jun Zhuang, Lin Cai, Tang Li and Zhijian Hu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Cancer.

In The Last Decade

Fei He

64 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fei He China 21 643 367 223 153 125 67 1.1k
Carlo Capalbo Italy 22 838 1.3× 326 0.9× 386 1.7× 128 0.8× 85 0.7× 54 1.4k
Guodong Liu China 18 470 0.7× 334 0.9× 253 1.1× 166 1.1× 124 1.0× 59 1.1k
Szu‐Ta Chen Taiwan 23 1.0k 1.6× 416 1.1× 312 1.4× 142 0.9× 84 0.7× 50 1.7k
Zhen Zeng China 19 579 0.9× 261 0.7× 297 1.3× 133 0.9× 109 0.9× 63 1.4k
Wenlin Bai China 20 451 0.7× 345 0.9× 184 0.8× 139 0.9× 269 2.2× 61 1.2k
Lei Fan China 23 587 0.9× 422 1.1× 257 1.2× 115 0.8× 75 0.6× 66 1.3k
Rui Qiao China 20 805 1.3× 244 0.7× 563 2.5× 195 1.3× 94 0.8× 56 1.6k
Jing Cui China 20 412 0.6× 253 0.7× 237 1.1× 188 1.2× 101 0.8× 70 1.2k
Changjing Cai China 19 634 1.0× 371 1.0× 362 1.6× 227 1.5× 104 0.8× 52 1.2k

Countries citing papers authored by Fei He

Since Specialization
Citations

This map shows the geographic impact of Fei He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei He more than expected).

Fields of papers citing papers by Fei He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei He. The network helps show where Fei He may publish in the future.

Co-authorship network of co-authors of Fei He

This figure shows the co-authorship network connecting the top 25 collaborators of Fei He. A scholar is included among the top collaborators of Fei He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei He. Fei He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Haojie, et al.. (2021). LincRNA‐p21 alleviates atherosclerosis progression through regulating the miR‐221/SIRT1/Pcsk9 axis. Journal of Cellular and Molecular Medicine. 25(19). 9141–9153. 23 indexed citations
3.
Liu, Zhiqiang, Zhiwen Huang, Fa Chen, et al.. (2021). Serum Uric Acid and Cardiovascular or All-Cause Mortality in Peritoneal Dialysis Patients: A Systematic Review and Meta-Analysis. Frontiers in Cardiovascular Medicine. 8. 751182–751182. 6 indexed citations
4.
Zhao, Jianhui, et al.. (2021). Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma. Frontiers in Genetics. 12. 714697–714697. 20 indexed citations
5.
6.
Xu, Xin, Zhiqiang Liu, Minglian Qiu, et al.. (2020). Combined and interaction effect of chlamydia pneumoniae infection and smoking on lung cancer: a case-control study in Southeast China. BMC Cancer. 20(1). 903–903. 13 indexed citations
7.
Li, Xin, Wenbin Jiang, Yixin Liu, et al.. (2019). A qualitative transcriptional signature for the histological reclassification of lung squamous cell carcinomas and adenocarcinomas. BMC Genomics. 20(1). 8 indexed citations
8.
9.
Wang, Dayong, Yage Chen, Shiyu Liu, et al.. (2019). PEST-containing nuclear protein regulates cell proliferation, migration, and invasion in lung adenocarcinoma. Oncogenesis. 8(3). 22–22. 20 indexed citations
10.
11.
Li, Wei, Fei He, Wen Zhang, Wen‐Hua Chen, & Bo Yu. (2018). Bioinformatics analysis of microarray data to reveal the pathogenesis of diffuse intrinsic pontine glioma. Biological Research. 51(1). 26–26. 14 indexed citations
12.
Zhang, Guoyu, Dan Lu, Shaofeng Duan, et al.. (2018). Hydrogen Sulfide Alleviates Lipopolysaccharide‐Induced Diaphragm Dysfunction in Rats by Reducing Apoptosis and Inflammation through ROS/MAPK and TLR4/NF‐κB Signaling Pathways. Oxidative Medicine and Cellular Longevity. 2018(1). 9647809–9647809. 49 indexed citations
13.
He, Fei, Li‐Mei Chen, Qiuping Xu, et al.. (2017). A case–control study of the association between self-reported occupational and recreational physical activity and lung cancer. Medicine. 96(36). e7923–e7923. 5 indexed citations
14.
He, Fei, Jianbo Lin, Tingting Yu, et al.. (2016). [Interaction research on smoking and microRNA genes SNP related to lung cancer in Fujian Han population].. PubMed. 50(2). 168–74. 7 indexed citations
15.
Zhao, Hui, Haojie Wang, Yi Wang, et al.. (2016). The Rho GTPase RhoE exerts tumor-suppressing effects in human esophageal squamous cell carcinoma via negatively regulating epidermal growth factor receptor. Journal of Cancer Research and Therapeutics. 12(5). 60–60. 8 indexed citations
16.
Ye, Jun, Wei Chen, Zhi‐Yong Wu, et al.. (2016). Upregulated CTHRC1 promotes human epithelial ovarian cancer invasion through activating EGFR signaling. Oncology Reports. 36(6). 3588–3596. 16 indexed citations
17.
He, Fei, Rong Yang, Xiaoyu Li, et al.. (2015). Single nucleotide polymorphisms of the NF-κB and STAT3 signaling pathway genes predict lung cancer prognosis in a Chinese Han population. Cancer Genetics. 208(6). 310–318. 3 indexed citations
18.
19.
Zeng, Xiang‐Tian, et al.. (2011). Caveolin-1 is related to invasion, survival, and poor prognosis in hepatocellular cancer. Medical Oncology. 29(2). 977–984. 54 indexed citations
20.
Zhao, Yuan, Tianhua Zhou, Aiqing Li, et al.. (2009). A Potential Role of Collagens Expression in Distinguishing Between Premalignant and Malignant Lesions in Stomach. The Anatomical Record. 292(5). 692–700. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carlo Capalbo Breakdown of academic impact, for papers by Guodong Liu Breakdown of academic impact, for papers by Szu‐Ta Chen Breakdown of academic impact, for papers by Zhen Zeng Breakdown of academic impact, for papers by Wenlin Bai Breakdown of academic impact, for papers by Lei Fan Breakdown of academic impact, for papers by Rui Qiao Breakdown of academic impact, for papers by Jing Cui Breakdown of academic impact, for papers by Changjing Cai
Rankless by CCL
2026